𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines

✍ Scribed by Kamegai, H; Seino-Noda, H; Ezoe, S; Matsumura, I; Kanakura, Y; Sasaki, H; Hayakawa, J; Terai, Y; Kanemura, M; Tanabe-Kimura, A


Book ID
110072908
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
257 KB
Volume
27
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Mechanism of interaction between cisplat
✍ Alissar Nehmé; Nicolas Albin; Marie Josée Caliaro; Sylvie Guichard; Suzanne Joza 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 857 KB

## Abstract Human ovarian carcinoma cells (2008 and its cisplatin‐resistant sub‐line 2008/C13\*) were sensitized to cisplatin by treatment with human recombinant gamma interferon (IFNγ). IFNγ produced no significant change in the uptake of CDDP. Exposure of 2008 and 2008/C13\* cells to IFNγ resulte

Comparative gene expression profiling re
✍ Claudio Scafoglio; Concetta Ambrosino; Luigi Cicatiello; Lucia Altucci; Mario Ar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

## Abstract Antiestrogens used for breast cancer (BC) treatment differ among each other for the ability to affect estrogen receptor (ER) activity and thereby inhibit hormone‐responsive cell functions and viability. We used high‐density cDNA microarrays for a comprehensive definition of the gene pat